Amanda Waier

Amanda Waier, CPA, CMA, currently serves as the Director of SEC Reporting and Operational Accounting at Evofem Biosciences, a role assumed in July 2023. Previous experience includes Senior Director of Financial Reporting & Technical Accounting at Curaleaf, where Amanda managed complex financial statement filings, led the implementation of a stock-based compensation service provider, and conducted technical accounting analyses. Prior positions include Senior Financial Analyst and various roles at Weyerhaeuser, Applied Materials, and Deloitte, where responsibilities ranged from financial statement preparation and analysis to audits and internal controls. Amanda holds an MS in Accounting from UNLV Lee Business School, an MBA from Baker University, and a Bachelor’s degree in Psychology from The University of Kansas.